Cite
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
MLA
András Kotschy, et al. “Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.” Journal of Medicinal Chemistry, vol. 64, June 2021, pp. 8971–91. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7aa669f3368474f2d06cdec15c347340&authtype=sso&custid=ns315887.
APA
András Kotschy, Allan E. Surgenor, Andrea Fiumana, James Brooke Murray, Andrew Massey, Thomas Edmonds, Nicolas Foloppe, Didier Demarles, Pawel Dokurno, Mike Burbridge, Francisco Cruzalegui, K Benwell, Roderick E. Hubbard, Stuart C. Ray, Walmsley David, & Julia Smith. (2021). Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B. Journal of Medicinal Chemistry, 64, 8971–8991.
Chicago
András Kotschy, Allan E. Surgenor, Andrea Fiumana, James Brooke Murray, Andrew Massey, Thomas Edmonds, Nicolas Foloppe, et al. 2021. “Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.” Journal of Medicinal Chemistry 64 (June): 8971–91. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7aa669f3368474f2d06cdec15c347340&authtype=sso&custid=ns315887.